Stylus (Series A)
Funding Details
Awarder
Inbox
Date Award
May 16, 2025
Vertical
Gene Editing
Funding URL
View Funding Page
Funding Amount
$85,000,000
Company Info
Market
Biotechnology
Coinvestors
Johnson & Johnson, Eli Lilly
Company Description

Stylus is a newly unveiled gene-editing biotech company focused on innovative solutions in the biotechnology sector.

Links
Back to HomeBack to Gene Editing DealsView Funding Announcement